DisclosurePeptide Association LLC is a for-profit company. We receive compensation from the clinical providers listed on this site. We are not an accrediting body, a licensing board, or a government-affiliated organization. See exactly how we make money.
The compound database
Peptide Database
264 therapeutic peptides with research summaries, clinical findings, and regulatory status. Every claim is cited.
- FDA-approved
- 90
- FDA-approved
- Awaiting FDA
- 8
- Awaiting FDA
- No lawful pathway
- 166
- No lawful pathway
- 001
Semaglutide (Ozempic/Wegovy)
A glucagon-like peptide-1 receptor agonist (GLP-1 RA) that differs from native GLP-1 by two amino acid substitutions (about 94% sequence identity) plus a fatty…
Metabolic · FDA Approved · Subcutaneous injection (weekly), Oral (daily - Rybelsus)
FDA-approved - 002
Tirzepatide (Mounjaro/Zepbound)
A once-weekly dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist. Tirzepatide activates both incretin pathways, and in…
Metabolic · FDA Approved · Subcutaneous injection (weekly)
FDA-approved - 003
Retatrutide
An investigational once-weekly triple hormone receptor agonist targeting GIP, GLP-1, and glucagon receptors, not yet FDA approved. The glucagon receptor…
Metabolic · In Clinical Trials · Subcutaneous injection (weekly)
No lawful pathway - 004
AOD-9604
A modified fragment of the C-terminus of human growth hormone, consisting of hGH residues 177-191 with an added N-terminal tyrosine (16 amino acids). AOD-9604…
Metabolic · Investigational · Subcutaneous injection, Oral
Awaiting FDA - 005
Liraglutide (Saxenda/Victoza)
A GLP-1 receptor agonist with 97% homology to native GLP-1, modified with a 16-carbon fatty acid chain that binds albumin and protects against DPP-4…
Metabolic · FDA Approved · Subcutaneous injection (daily)
FDA-approved - 006
Exenatide (Byetta/Bydureon)
A synthetic version of exendin-4, a 39-amino acid peptide originally isolated from the venom of the Gila monster lizard (Heloderma suspectum). Exenatide shares…
Metabolic · FDA Approved · Subcutaneous injection (twice daily or weekly extended-release)
FDA-approved - 007
Glucagon
A 29-amino acid peptide hormone produced by alpha cells of the pancreatic islets of Langerhans. Glucagon acts on the liver via the glucagon receptor (GCGR), a…
Metabolic · FDA Approved · Subcutaneous injection, Intramuscular injection, Intranasal
FDA-approved - 008
Pramlintide (Symlin)
A synthetic analog of amylin (islet amyloid polypeptide), a 37-amino acid peptide hormone co-secreted with insulin from pancreatic beta cells. Pramlintide has…
Metabolic · FDA Approved · Subcutaneous injection (before meals)
FDA-approved - 009
Dulaglutide (Trulicity)
A long-acting GLP-1 receptor agonist consisting of a GLP-1 analog fused to a modified human IgG4 Fc fragment, a design that retained full receptor activity…
Metabolic · FDA Approved · Subcutaneous injection (weekly)
FDA-approved - 010
Lixisenatide (Adlyxin)
A selective GLP-1 receptor agonist derived from exendin-4 with a modified C-terminal tail containing six lysine residues. Lixisenatide increases…
Metabolic · FDA Approved · Subcutaneous injection (daily)
FDA-approved - 011
Setmelanotide (Imcivree)
A cyclic peptide melanocortin-4 receptor (MC4R) agonist designed to restore MC4R signaling in patients with obesity caused by genetic defects in the…
Metabolic · FDA Approved · Subcutaneous injection (daily)
FDA-approved - 012
Orforglipron
Orforglipron is a non-peptide, oral small-molecule glucagon-like peptide-1 receptor (GLP-1R) agonist developed as an alternative to injectable GLP-1 drugs. It…
Metabolic · FDA Approved · Oral
FDA-approved - 013
Mazdutide
Mazdutide is a dual glucagon-like peptide-1 (GLP-1) and glucagon receptor agonist given as a once-weekly subcutaneous peptide injection. By co-activating both…
Metabolic · In Clinical Trials · Subcutaneous injection
No lawful pathway - 014
Survodutide
Survodutide is a dual agonist of the glucagon and glucagon-like peptide-1 (GLP-1) receptors, given as a once-weekly subcutaneous peptide injection. The…
Metabolic · In Clinical Trials · Subcutaneous injection
No lawful pathway - 015
CagriSema
CagriSema is a once-weekly combination of cagrilintide, a long-acting amylin analog, and semaglutide, a GLP-1 receptor agonist, both delivered as peptides by…
Metabolic · In Clinical Trials · Subcutaneous injection
No lawful pathway - 016
Amycretin
Amycretin is a single-molecule (unimolecular) agonist of both the GLP-1 receptor and the amylin receptor, developed by Novo Nordisk for obesity in both oral…
Metabolic · In Clinical Trials · Subcutaneous injection
No lawful pathway - 017
Efinopegdutide
Efinopegdutide (MK-6024) is a long-acting dual agonist of the GLP-1 and glucagon receptors given once weekly by subcutaneous injection. The compound combines…
Metabolic · In Clinical Trials · Subcutaneous injection
No lawful pathway - 018
Danuglipron
Danuglipron (PF-06882961) is an oral, non-peptide small-molecule agonist of the GLP-1 receptor that was developed for type 2 diabetes and obesity. It mimics…
Metabolic · Investigational · Oral
No lawful pathway - 019
Ecnoglutide
Ecnoglutide (XW003) is a long-acting GLP-1 receptor agonist peptide developed by Sciwind Biosciences for once-weekly subcutaneous use, with an oral tablet form…
Metabolic · In Clinical Trials · Subcutaneous injection
No lawful pathway - 020
Cotadutide
Cotadutide (MEDI0382) is a dual agonist of the GLP-1 and glucagon receptors formulated as a peptide for once-daily subcutaneous injection. It was designed to…
Metabolic · Investigational · Subcutaneous injection
No lawful pathway - 021
Glepaglutide
Glepaglutide is a long-acting GLP-2 receptor agonist peptide developed for the treatment of short bowel syndrome (SBS), designed as a ready-to-use injection.…
Metabolic · In Clinical Trials · Subcutaneous injection
No lawful pathway - 022
Apraglutide
Apraglutide is a long-acting glucagon-like peptide-2 (GLP-2) receptor agonist given once weekly by subcutaneous injection, designed to promote intestinal…
Metabolic · In Clinical Trials · Subcutaneous injection
No lawful pathway - 023
Teduglutide (Gattex)
Teduglutide is a recombinant analogue of human glucagon-like peptide-2 (GLP-2) comprising 33 amino acids with a single amino acid substitution that confers…
Metabolic · FDA Approved · Subcutaneous injection
FDA-approved - 024
Beinaglutide
Beinaglutide is a recombinant human GLP-1 (rhGLP-1) used in China as a treatment for type 2 diabetes. Unlike long-acting GLP-1 analogues, it is short-acting…
Metabolic · In Clinical Trials · Subcutaneous injection
No lawful pathway - 025
Albiglutide (Tanzeum)
Albiglutide is a GLP-1 receptor agonist made of modified human GLP-1 sequences fused to human albumin, giving it an elimination half-life of about 5 days that…
Metabolic · FDA Approved · Subcutaneous injection
FDA-approved - 026
Taspoglutide
Taspoglutide is a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist derived from human GLP-1 with amino acid substitutions designed to resist…
Metabolic · Investigational · Subcutaneous injection
No lawful pathway - 027
Pemvidutide
Pemvidutide (ALT-801) is a dual receptor agonist targeting the glucagon-like peptide-1 (GLP-1) and glucagon receptors, given once weekly by subcutaneous…
Metabolic · In Clinical Trials · Subcutaneous injection
No lawful pathway - 028
Cagrilintide
Cagrilintide is a long-acting amylin analogue given once weekly by subcutaneous injection and developed for weight management. Amylin is a 37-amino-acid…
Metabolic · In Clinical Trials · Subcutaneous injection
No lawful pathway - 029
Enlicitide
Enlicitide (enlicitide decanoate, formerly MK-0616) is an oral macrocyclic peptide that inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9)…
Metabolic · FDA Approved · Oral
FDA-approved
Index · all 264 peptides, A–Z
- 177Lu-PSMA-617 (Pluvicto)
- Abaloparatide (Tymlos)
- Abarelix (Plenaxis)
- ACE-031 (Ramatercept)
- ACTH (4-10) Analogs
- Adrenomedullin
- Afamelanotide (Scenesse)
- AHK-Cu (Copper Tripeptide-3)
- Albiglutide (Tanzeum)
- Alpha-Defensin 5
- Alpha-MSH
- Amycretin
- Anamorelin (Adlumiz)
- Angiotensin (1-7)
- Angiotensin II (Giapreza)
- AOD-9604
- Apelin-13
- Apraglutide
- ARA-290
- Argireline (Acetyl Hexapeptide-8)
- Atosiban
- Atrial Natriuretic Peptide (ANP)
- Beinaglutide
- Beta-Defensin 2
- Beta-Defensin 3
- Biopeptide CL (Palmitoyl Tripeptide-5)
- Bioregulator Peptides (Khavinson)
- Bivalirudin (Angiomax)
- BMP-2 (Bone Morphogenetic Protein-2)
- BMP-7 (Osteogenic Protein-1)
- Body Protection Compound (BPC) Variants
- Bombesin Analog Tracers
- Bortezomib (Velcade)
- BPC-157
- Brain Natriuretic Peptide (BNP)
- Bromantane-adjacent Peptides
- Bursin
- Buserelin (Suprefact)
- C-type Natriuretic Peptide (CNP)
- Cagrilintide
- CagriSema
- Calcitonin
- Calcitonin Gene-Related Peptide (CGRP)
- Capromorelin (Entyce)
- Carbetocin
- Carfilzomib (Kyprolis)
- Carperitide (h-ANP)
- Cathelicidin LL-37 Fragments
- Cerebrolysin
- Cetrorelix (Cetrotide)
- Cetrorelix (Cetrotide) Analog
- Cholecystokinin (CCK)
- Choriogonadotropin Alfa (Ovidrel)
- Chrysalin (TP508)
- CJC-1295
- Colistin (Polymyxin E)
- Collagen Tripeptide F (CTP-F)
- Conantokin-G
- Copper Peptide (Prezatide Copper Acetate)
- Corifollitropin Alfa (Elonva)
- Cortexin
- Cosyntropin (Cortrosyn)
- Cotadutide
- Dalargin
- Danuglipron
- Decorinyl (Tripeptide-10 Citrulline)
- Defensin HNP-1
- Degarelix (Firmagon)
- Deltorphin
- Dermorphin
- Desmopressin (DDAVP)
- Difelikefalin (Korsuva)
- Dihexa
- DOTATATE (Ga-68)
- DSIP (Delta Sleep-Inducing Peptide)
- Dulaglutide (Trulicity)
- Dynorphin A
- Ecnoglutide
- Efinopegdutide
- Elagolix (Orilissa)
- Eltrombopag Peptide Mimetics
- Endomorphin-1
- Endomorphin-2
- Enfuvirtide (Fuzeon)
- Enlicitide
- Epithalon (Epitalon)
- Eptifibatide (Integrilin)
- Exenatide (Byetta/Bydureon)
- Eyeseryl (Acetyl Tetrapeptide-5)
- FGL Peptide
- Follistatin-344
- Follitropin Alfa (Gonal-F)
- FOXO4-DRI
- Gadopentetate Peptide Conjugates
- Galanin
- Ganirelix
- Gastrin
- Gerontin (Pineal Gland Extract)
- GHK (Glycyl-Histidyl-Lysine)
- GHK-Cu
- Ghrelin (Native)
- Ghrelin Receptor Antagonists
- GHRH (Sermorelin 1-44)
- GHRP-1
- GHRP-2
- GHRP-6
- Glepaglutide
- Glucagon
- Glucagon Receptor Antagonist Peptides
- Gonadorelin (GnRH)
- Gonadotropin Releasing Hormone (GnRH) Agonists
- Goserelin (Zoladex)
- Gramicidin S
- Granulysin
- Guanylin
- Haloxyl (Chrysin + Palmitoyl Peptides)
- Hepcidin
- Hexarelin
- Histrelin (Vantas)
- Humanin
- Icatibant (Firazyr)
- IGF-1 DES (1-3)
- IGF-1 LR3 (Long-Arg3)
- Imuthiol (Diethyldithiocarbamate)
- Indolicidin
- Intranasal Insulin
- Ipamorelin
- Iseganan (IB-367)
- Kisspeptin
- Klotho Peptide
- KPV
- Lactoferricin
- Lanreotide (Somatuline Depot)
- Larazotide
- Leu-Enkephalin
- Leuphasyl (Pentapeptide-18)
- Leuprolide (Lupron)
- Leuprolide (Lupron) - Oncology
- Linaclotide (Linzess)
- Liraglutide (Saxenda/Victoza)
- Lixisenatide (Adlyxin)
- LL-37
- Lonapegsomatropin (Skytrofa)
- Lutetium-177 dotatate (Lutathera)
- Macimorelin (Macrilen)
- Magainin 2
- Matrikine Peptides
- Matrixyl (Palmitoyl Pentapeptide-4)
- Matrixyl 3000
- Matrixyl Synthe'6 (Palmitoyl Tripeptide-38)
- Mazdutide
- Mecasermin (Increlex)
- Melanotan II
- Melitane (Acetyl Hexapeptide-1)
- Melphalan Flufenamide (Pepaxto)
- Menotropin (Menopur)
- Met-Enkephalin
- MGF (Mechano Growth Factor)
- Mitochondrial-Targeted Peptides (MTP)
- MK-677 (Ibutamoren)
- Mod GRF 1-29 (CJC-1295 no DAC)
- Motilin
- MOTS-c
- Myristoyl Pentapeptide-17
- N-acetyl Selank Amidate
- N-acetyl Semax Amidate
- NAD+ Precursors (NMN)
- Nafarelin (Synarel)
- NAP (Davunetide)
- Nemifitide
- Nesiritide (Natrecor)
- Neuropeptide FF
- Neurotensin
- Nexagon (Gap Junction Peptide)
- Nisin
- Nociceptin / Orphanin FQ
- Obestatin
- Octreotide (Sandostatin)
- Omiganan
- OP-1 / BMP-7
- Orexin A
- Orexin B
- Orforglipron
- Osteogenic Growth Peptide (OGP)
- Oxytocin
- P21 (Peptide)
- Palmitoyl Tripeptide-1
- Palmitoylethanolamide (PEA)
- Pasireotide (Signifor)
- PEG-MGF
- Pegcetacoplan (Empaveli)
- Peginesatide (Omontys)
- Pegvisomant (Somavert)
- Pemvidutide
- Pentadeca Arginate (PDA)
- Pentagastrin
- Pentosan Polysulfate (Elmiron)
- Peptide YY (PYY 3-36)
- Pexiganan (MSI-78)
- Pinealon
- Plecanatide (Trulance)
- Plitidepsin (Aplidin)
- Polymyxin B
- Pramlintide (Symlin)
- PT-141 (Bremelanotide / Vyleesi)
- PTH (1-34) Analogs
- Relamorelin
- Relugolix (Orgovyx)
- Retatrutide
- RGD Peptide Tracers
- Rigin (Palmitoyl Tetrapeptide-7)
- Romiplostim (Nplate)
- Sclerostin Antibodies (Romosozumab)
- Secretin
- Selank
- Semaglutide (Ozempic/Wegovy)
- Semax
- Serelaxin (Relaxin-2)
- Sermorelin
- Setmelanotide (Imcivree)
- Sinapultide (KL4 Surfactant)
- Sirtuin-Activating Peptides
- SNAP-8 (Acetyl Octapeptide-3)
- Somapacitan (Sogroya)
- Somatostatin (Native)
- Somatropin (Genotropin)
- Spadin
- Splenopentin
- SS-31 (Elamipretide)
- Survodutide
- SYN-AKE (Dipeptide Diaminobutyroyl Benzylamide Diacetate)
- Tabimorelin
- Taspoglutide
- TB-500 (Thymosin Beta-4)
- Teduglutide (Gattex)
- Teriparatide (Forteo)
- Terlipressin
- Tesamorelin (Egrifta)
- Thrombopoietin (TPO)
- Thymalin
- Thymogen (Glutamyl-Tryptophan)
- Thymopentin (TP-5)
- Thymosin Alpha 1 (Zadaxin)
- Thymosin Beta-4 Fragment (TB4-Frag)
- Thymostimulin (TP-1)
- Thymulin
- Tirbanibulin (Klisyri)
- Tirzepatide (Mounjaro/Zepbound)
- Triptorelin (Trelstar)
- Trylagen (Tripeptide-10 Complex)
- Tuftsin
- Ularitide (Urodilatin)
- Urocortin 1
- Urocortin 2
- Urocortin 3
- Uroguanylin (Dolcanatide)
- Vantictumab
- Vapreotide
- Vasopressin (ADH)
- Vialox (Pentapeptide-3)
- Vilon (Lys-Glu)
- VIP (Vasoactive Intestinal Peptide)
- Vosoritide (Voxzogo)
- Ziconotide (Prialt)
Important Medical Disclaimer
The information provided by the Peptide Association is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified, licensed healthcare provider before beginning any peptide therapy, supplement regimen, or making changes to an existing treatment plan.
Peptide therapies discussed on this site may not be FDA-approved for all listed indications. Individual results vary. The Peptide Association does not prescribe, diagnose, or treat any medical condition. Clinicians in our network are independently licensed practitioners; the Association checks each clinician’s NPI record but does not employ or directly supervise these clinicians.
© 2026 The Peptide Association. All rights reserved. Content on this site is protected under applicable intellectual property laws. The Peptide Association is not a medical practice.